Clinical Trial Update: Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating Xevinapant in combination with radiation and chemotherapy for head and neck cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Neoplasms
• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• Xevinapant (Xevinapant)

Snippet

Sponsor: University of Chicago | Conditions: Head and Neck Cancer, Head and Neck Neoplasms | Phase 1 | Status: TERMINATED